Article
Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin.
Digestive diseases and sciences - 1 Jun 2011
Al-Hamoudi Waleed, Mohamed Hazem, Abaalkhail Faisal, Kamel Yaser, Al-Masri Nasser, Allam Naglaa, Alqahtani Saleh, Al-Sofayan Mohammed, Khalaf Hatem, Al-Sebayel Mohammed, Al-Jedai Ahmed, Abdo Ayman
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) recurrence after liver transplantation (LT) is universal and tends to be more aggressive. Data on post-transplant HCV genotype 4 treatment is scarce. The aim of this study is to assess the safety and efficacy of pegylated interferon alpha-2a (PEG-IFN) in combination with ribavirin in the treatment of recurrent HCV genotype 4 after LT. METHODS: Twenty-five patients infected with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.